| (in millions $) | 30 Jul 2024 | 1 May 2024 | 30 Dec 2023 | 1 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $494 | $644 | $556 | $485 |
| Inventory | $509 | $531 | $528 | $483 |
| Total current assets | $3767 | $4484 | $5266 | $4683 |
| Long term investments | ||||
| Property, plant & equipment | $43387 | $42753 | $41381 | $41229 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $49602 | $49761 | $49120 | $49756 |
| Current liabilities | ||||
| Accounts payable | $1063 | $1103 | $1168 | $1103 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $13385 | $12396 | $11481 | $11008 |
| Long term debt | $27154 | $28544 | $28483 | $29516 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $42788 | $43079 | $42238 | $42796 |
| Shareholders' equity | ||||
| Retained earnings | $62 | -$29 | $185 | $233 |
| Other shareholder equity | -$1919 | -$1938 | -$1939 | -$1896 |
| Total shareholder equity | ||||
| (in millions $) | 30 Dec 2023 | 31 Jan 2023 | 29 Nov 2021 | 29 Nov 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $8939 | $9513 | ||
| Short term investments | $200 | |||
| Net receivables | $556 | $395 | $246 | $427 |
| Inventory | $528 | $428 | $356 | $335 |
| Total current assets | $5266 | $7492 | $10133 | $10563 |
| Long term investments | $242 | $289 | ||
| Property, plant & equipment | $41381 | $39961 | $39440 | $39443 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $43030 | |||
| Total investments | ||||
| Total assets | $49120 | $51703 | $53344 | $53593 |
| Current liabilities | ||||
| Accounts payable | $1168 | $1050 | $797 | $624 |
| Deferred revenue | ||||
| Short long term debt | $1930 | $1747 | ||
| Total current liabilities | $11481 | $10605 | $10408 | $8686 |
| Long term debt | $28483 | $31953 | $28511 | $22135 |
| Total noncurrent liabilities | $24352 | |||
| Total debt | ||||
| Total liabilities | $42238 | $44639 | $41200 | $33038 |
| Shareholders' equity | ||||
| Retained earnings | $185 | $269 | $6448 | $16075 |
| Other shareholder equity | -$1939 | -$1982 | -$1502 | -$1436 |
| Total shareholder equity | $14863 | $20555 | ||
| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 30 Dec 2023 | 30 Dec 2022 | 29 Nov 2021 | 29 Nov 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $21593 | $12168 | $1908 | $5594 |
| Cost of revenue | $2717 | $4760 | ||
| Gross Profit | $7276 | $851 | -$809 | $834 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1885 | $1885 | ||
| Total operating expenses | $5320 | $4790 | $8181 | $10511 |
| Operating income | -$6273 | -$4917 | ||
| Income from continuing operations | ||||
| EBIT | -$6273 | -$4917 | ||
| Income tax expense | $13 | $14 | -$21 | -$17 |
| Interest expense | -$1833 | -$1535 | -$1601 | -$895 |
| Net income | ||||
| Net income | -$74 | -$6093 | -$9501 | -$10236 |
| Income (for common shares) | -$9501 | -$10236 | ||
| (in millions $) | 1 Jul 2024 | 29 Mar 2024 | 30 Dec 2023 | 1 Oct 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$3384 | -$2163 | -$2810 | -$2322 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1066 | $314 | -$5102 | -$4113 |
| Effect of exchange rate | -$6 | -$3 | $17 | $25 |
| Change in cash and equivalents | -$650 | -$85 | -$3614 | -$3050 |
| (in millions $) | 30 Dec 2023 | 30 Dec 2022 | 29 Nov 2021 | 29 Nov 2020 |
|---|---|---|---|---|
| Net income | -$9501 | -$10236 | ||
| Operating activities | ||||
| Depreciation | $2241 | |||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$6301 | |||
| Investing activities | ||||
| Capital expenditures | -$3620 | |||
| Investments | ||||
| Total cash flows from investing | -$2810 | -$4767 | -$3240 | |
| Financing activities | ||||
| Dividends paid | -$689 | |||
| Sale and purchase of stock | ||||
| Net borrowings | $16251 | |||
| Total cash flows from financing | -$5089 | $3577 | $18650 | |
| Effect of exchange rate | $17 | -$79 | $53 | |
| Change in cash and equivalents | -$3601 | -$2940 | $9162 | |
| Market cap | $40.16B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.26B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.28 |
| Quick ratio | 0.24 |